↓ Skip to main content

Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial

Overview of attention for article published in Trials, August 2022
Altmetric Badge

Mentioned by

news
4 news outlets
twitter
162 X users

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial
Published in
Trials, August 2022
DOI 10.1186/s13063-022-06649-3
Pubmed ID
Authors

Anan Manomaipiboon, Kittisak Pholtawornkulchai, Sujaree Poopipatpab, Swangjit Suraamornkul, Jakravoot Maneerit, Wiroj Ruksakul, Uraporn Phumisantiphong, Thananda Trakarnvanich

X Demographics

X Demographics

The data shown below were collected from the profiles of 162 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 10%
Other 2 7%
Student > Master 2 7%
Lecturer 1 3%
Student > Ph. D. Student 1 3%
Other 1 3%
Unknown 20 67%
Readers by discipline Count As %
Medicine and Dentistry 5 17%
Business, Management and Accounting 2 7%
Engineering 1 3%
Unknown 22 73%